Tags: Thesis Statement For Gun Control LawsArgumentative Essay On Illegal ImmigrationPakistani Urdu ThesisResearch Paper Structure MlaEssay On Why Homework Should Not Be BannedIntroduction Of Crime EssayConan Doyle Speckled Band EssaySongs For HomeworkPhd Thesis Petroleum Geology
She also writes the agenda content for solid tumor oncology summits and forums to educate community doctors on updates in cancer treatment and bring together KOLs to debate future directions and controversial ideas.Assistant Manager, Syndicated Products Thai Cao joined DAVA Oncology in February 2014 as a Medical Writer.He has worked on a variety of successful projects helping various pharmaceutical companies to accelerate their clinical trials. Chima acquired his medical degree from a joint Global Scholar program between Northumbria University in Newcastle, England and St. Upon completion, he served as an associate professor of clinical medical sciences in Sacramento, California. Chima then joined a Silicon Valley startup as the Lead Medical Consultant and eventually transitioned to his current role at DAVA Oncology.
Viktoriya participated in 2008 Beijing and 2012 London Olympic Games. Executive Director, Meetings, Branding & Partnerships Gregory Pascal Pynes, MPA joined DAVA in 2011 after leading the meetings team at Physicians Education Resource for 10 years.
Gregory has managed and participated in over 1000 global meetings ranging from medical and commercial advisory boards, CME and Non-CME meetings for the community oncologist, and clinical trial accrual workshops.
DAVA’s trial acceleration services optimize the recruitment and retention of patients in cancer clinical trialsusing physician-focused approaches including education workshops, medical feasibility assessment, site ID, site motivation, and referral outreach.
DAVA conducts non-CME, oncology-focused meetings under the Oncology Meeting Innovations name.
There arethree types of meetings: global summits, regional summits, and expert forums.
The goal of these programs is toimprove the dissemination of knowledge between researchers, innovators, and implementers in the treatment of cancer.He has been included the strategic analysis including clinical development plans and landscape comparisons of oncology treatments for multiple tumor types, ranging from solid tumors to hematological malignancies.Currently, he updates and quality checks DAVA’s tumor types and pathway training decks, as well as train new colleagues.She brings key insights from her research work in biochemistry and cancer biology.Oindrilla has a Ph D in Biochemistry from the University of Hyderabad, India, with breast cancer as her area of research.Clinical Trial Specialist Brandon joined DAVA in June 2019 and is currently working as a Clinical Trial Specialist for DAVA Oncology’s Accelerating Clinical Trial team.Brandon received Bachelor of Science degrees in Biology and Psychology from Southern Methodist University in 2017.Before joining DAVA, he was briefly involved in molecular research focusing on mechanisms in which deprivation of heme and oxygen signaling affects diseases, including cancer.Thai received both his Master in Biotechnology and Bachelor of Arts in Biology from the University of Texas at Dallas.Physician Liaison Elizabeth Chism is the lead OMI physician liaison and DAVA Oncology copy editor.She holds a Bachelor’s degree in Communication Sciences & Speech Pathology and Audiology from Abilene Christian University and a Master’s degree in Journalism from the University of North Texas.